Rare genetic disorders

    We support innovative biotechs in Italy as they push promising research programs in rare genetic disorders towards preclinical and clinical development.

    Our unique collaboration with the Telethon Foundation aims to bring Italian scientific excellence to the world stage. Our mission is to foster a thriving biotech ecosystem in Italy.

    CloseFundAMT
    2018Sofinnova Telethon Fund€108 million
    • Close: 2018

      Fund: Sofinnova Telethon Fund

      AMT: €108 million

    “There has to be more willingness to invest in the early stage. If nobody had invested in mRNA technology 10 years ago, I don't think we would have had the Covid vaccine in less than one year.”

    “We come from the tech transfer world so we understand what it takes to build companies around the expertise at universities and institutions."

    The
    Team

    Companies

    Fund iteration
    Status
    Partner
    Welcome to our new website – a fresh look that represents a new SofinnovaFind out more